{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:43:19Z","timestamp":1777876999482,"version":"3.51.4"},"reference-count":52,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Therapeutic Advances in Musculoskeletal"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>The management of psoriatic arthritis (PsA) has long been equated with that of rheumatoid arthritis (RA), particularly because methotrexate (MTX) was found efficient in RA in the 1990s. However, results of collective evidence-based medicine, included and argued in this narrative review, do not currently support the use of MTX as first-line therapy in severe PsA. A recent Cochrane systematic review examining the efficacy of MTX in PsA concluded that low-dose MTX was only slightly more effective than placebo. Questions about a structural effect of MTX in PsA remains non-elucidated. Even if tolerance data on MTX are more consensual and adverse events generally non-severe, subjective side effects such as fatigue might lead to MTX withdrawal based on the patient\u2019s decision. PsA patients with axial disease, radiographic lesions, and extensive and disabling skin or joint involvement should receive early treatment with targeted therapy and no longer with MTX. Finally, the usefulness of MTX combined with targeted therapies is limited. MTX does not affect efficacy but only seems to increase the therapeutic maintenance of monoclonal TNF inhibitors. This narrative review may help clarify the place of MTX in PsA management. It allows for reflection on the evolution of current concepts and practices.<\/jats:p>","DOI":"10.1177\/1759720x221092376","type":"journal-article","created":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T08:00:41Z","timestamp":1650355241000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":16,"title":["Is there still a place for methotrexate in severe psoriatic arthritis?"],"prefix":"10.1177","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4951-4032","authenticated-orcid":false,"given":"Renaud","family":"Felten","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Centre de R\u00e9f\u00e9rence National des Maladies Auto-Immunes Syst\u00e9miques Rares CIC-P Hautepierre, INSERM 1434, University Hospital of Strasbourg, Strasbourg, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gr\u00e9goire","family":"Lambert De Cursay","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Rheumatology, Infectious and Tropical Diseases, Hospital of Brive, Brive-la-Gaillarde, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1009-8518","authenticated-orcid":false,"given":"Eric","family":"Lespessailles","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, PRIMMO, Regional Hospital of Orleans, 45067 Orleans, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2022,4,19]]},"reference":[{"key":"bibr1-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1002\/art.40726"},{"key":"bibr2-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217159"},{"key":"bibr3-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-eular.4091"},{"key":"bibr4-1759720X221092376","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.39573","volume":"68","author":"Coates LC","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"bibr5-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1964.03070100037007"},{"key":"bibr6-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270403"},{"key":"bibr7-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes001"},{"key":"bibr8-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00347-5"},{"key":"bibr9-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150614"},{"key":"bibr10-1759720X221092376","volume":"1","author":"Wilsdon TD","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr11-1759720X221092376","first-page":"469","volume":"35","author":"Chandran V","year":"2008","journal-title":"J Rheumatol"},{"key":"bibr12-1759720X221092376","first-page":"241","volume":"22","author":"Abu-Shakra M","year":"1995","journal-title":"J Rheumatol"},{"key":"bibr13-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202959"},{"key":"bibr14-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15340"},{"key":"bibr15-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12495"},{"key":"bibr16-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S300402"},{"key":"bibr17-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32127-4"},{"key":"bibr18-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2018.11.011"},{"key":"bibr19-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14314"},{"key":"bibr20-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-016-0564-5"},{"key":"bibr21-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154744"},{"key":"bibr22-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h1269"},{"key":"bibr23-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.113308"},{"key":"bibr24-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2546-x"},{"key":"bibr25-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15305"},{"key":"bibr26-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1002\/art.21306"},{"key":"bibr27-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151290"},{"key":"bibr28-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.032268"},{"key":"bibr29-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1002\/art.24403"},{"key":"bibr30-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu415"},{"key":"bibr31-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1002\/art.40851"},{"key":"bibr32-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202347"},{"key":"bibr33-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1080\/03009742.2019.1600717"},{"key":"bibr34-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-020-02388-5"},{"key":"bibr35-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-020-00250-3"},{"key":"bibr36-1759720X221092376","first-page":"1597","volume":"77","author":"Kirkham B","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"bibr37-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60594-2"},{"key":"bibr38-1759720X221092376","unstructured":"Neither add-on nor withdrawal of methotrexate impacts efficacy of IL12\/23 inhibition in active PsA: data from a multicenter investigator-initiated randomized placebo-controlled clinical trial on arthritis, dactylitis, enthesitis, psoriasis, qol and function. ACR meeting abstracts, https:\/\/acrabstracts.org\/abstract\/neither-add-on-nor-withdrawal-of-methotrexate-impacts-efficacy-of-il12-23-inhibition-in-active-psa-data-from-a-multicenter-investigator-initiated-randomized-placebo-controlled-clinical-trial-on-arthr\/ (accessed 16 November 2021)."},{"key":"bibr39-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-020-00209-4"},{"key":"bibr40-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30339-8"},{"key":"bibr41-1759720X221092376","unstructured":"Upadacitinib as monotherapy and in combination with non-biologic DMARDs for the treatment of psoriatic arthritis: subgroup analysis from two phase 3 trials. ACR meeting abstracts, https:\/\/acrabstracts.org\/abstract\/upadacitinib-as-monotherapy-and-in-combination-with-non-biologic-dmards-for-the-treatment-of-psoriatic-arthritis-subgroup-analysis-from-two-phase-3-trials\/ (accessed 29 June 2021)."},{"key":"bibr42-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14926"},{"key":"bibr43-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1002\/art.23333"},{"key":"bibr44-1759720X221092376","unstructured":"Comparing adalimumab etanercept as first line agents in patients with psoriatic arthritis. Data from the Rhumadata\u00ae Clinical Database and Registry. ACR meeting abstracts, https:\/\/acrabstracts.org\/abstract\/comparing-adalimumab-and-etanercept-as-first-line-agents-in-patients-with-psoriatic-arthritis-data-from-the-rhumadata-clinical-database-and-registry\/ (accessed 29 June 2021)."},{"key":"bibr45-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2017.1329504"},{"key":"bibr46-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.4103\/2542-3975.274078"},{"key":"bibr47-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1424-8"},{"key":"bibr48-1759720X221092376","volume":"2","author":"Chen J","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"bibr49-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16915"},{"key":"bibr50-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1010858"},{"key":"bibr51-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.02.019"},{"key":"bibr52-1759720X221092376","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206624"}],"container-title":["Therapeutic Advances in Musculoskeletal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1759720X221092376","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1759720X221092376","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1759720X221092376","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:38:27Z","timestamp":1777588707000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1759720X221092376"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":52,"alternative-id":["10.1177\/1759720X221092376"],"URL":"https:\/\/doi.org\/10.1177\/1759720x221092376","relation":{},"ISSN":["1759-720X","1759-7218"],"issn-type":[{"value":"1759-720X","type":"print"},{"value":"1759-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"article-number":"1759720X221092376"}}